Detalhe da pesquisa
1.
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 - a Nordic Lymphoma Group study.
Haematologica
; 109(4): 1171-1183, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646663
2.
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors.
Haematologica
; 108(4): 1092-1104, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519324
3.
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors.
Br J Haematol
; 193(3): 520-531, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686666
4.
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma.
Br J Haematol
; 191(5): 796-805, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748433
5.
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk.
BMC Cancer
; 20(1): 1202, 2020 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33287742
6.
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
Int J Cancer
; 144(11): 2695-2706, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447004
7.
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.
Blood
; 130(17): 1903-1910, 2017 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819011
8.
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.
BMC Cancer
; 18(1): 466, 2018 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695239
9.
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
Blood
; 125(17): 2669-77, 2015 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736311
10.
Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
BMC Cancer
; 16: 493, 2016 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27430213
11.
DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.
BMC Cancer
; 15: 273, 2015 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25880212
12.
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.
Br J Haematol
; 166(1): 98-108, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24684350
13.
Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.
Proc Natl Acad Sci U S A
; 108(34): 14252-7, 2011 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21844363
14.
Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma.
Front Immunol
; 15: 1373269, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566987
15.
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study.
JMIR Res Protoc
; 13: e55723, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436589
16.
Protein expression profiling of formalin-fixed paraffin-embedded tissue using recombinant antibody microarrays.
J Proteome Res
; 12(12): 5943-53, 2013 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24063262
17.
Switching characteristics of an InP photonic crystal nanocavity: experiment and theory.
Opt Express
; 21(25): 31047-61, 2013 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24514679
18.
Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma.
Cancers (Basel)
; 15(8)2023 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190290
19.
Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer.
Oncoimmunology
; 12(1): 2206725, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139184
20.
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma.
Blood Adv
; 7(18): 5304-5313, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37389827